The Community Guide

- gsearch

Search Results

Narrow Results:

2015 1
2013 1
2011 1

Botswana 1

Journal Article 3

1 - 3 of 3 Results

Refine Results

Refine Results:

Clinical Trial in Botswana

CITE Title : Clinical Trial in Botswana Personal Author(s) : Gust, Deborah A.;Mosimaneotsile, Barudi;Mathebula, Unami;Chingapane, Balladiah;Gaul, Zaneta;Pals, Sherri L.;Samandari, Taraz; Published Date : Apr 25 2011 Source : PLoS One. 6(4). URL : https://stacks.cdc.gov/view/cdc/4317 Gust, Deborah A. et al. (2011). Clinical Trial in Botswana. 6(4). Gust, Deborah A. et al. "Clinical Trial in Botswana" 6, no. 4 (2011) Gust, Deborah A. et al. "Clinical Trial in Botswana" vol. 6, no. 4, 2011 Export RIS Citation Information.

:

Gust, Deborah A. ;

Mosimaneotsile, Barudi

Apr 25 2011 | PLoS One. 6(4).

:

BackgroundParticipant non-adherence and loss to follow-up can compromise the validity of clinical trial results. An assessment of these issues was mad...
Tuberculosis incidence after 36 months’ isoniazid prophylaxis in HIV-infected adults in Botswana: a posttrial observational analysis

CITE Title : Tuberculosis incidence after 36 months’ isoniazid prophylaxis in HIV-infected adults in Botswana: a posttrial observational analysis Personal Author(s) : Samandari, Taraz;Agizew, Tefera B.;Nyirenda, Samba;Tedla, Zegabriel;Sibanda, Thabisa;Mosimaneotsile, Barudi;Motsamai, Oaitse I.;Shang, Nong;Rose, Charles E.;Shepherd, James; Published Date : Jan 28 2015 Source : AIDS. 29(3):351-359 URL : https://stacks.cdc.gov/view/cdc/43112 Samandari, Taraz et al. (2015). Tuberculosis incidence after 36 months’ isoniazid prophylaxis in HIV-infected adults in Botswana: a posttrial observational analysis. 29(3). Samandari, Taraz et al. "Tuberculosis incidence after 36 months’ isoniazid prophylaxis in HIV-infected adults in Botswana: a posttrial observational analysis" 29, no. 3 (2015) Samandari, Taraz et al. "Tuberculosis incidence after 36 months’ isoniazid prophylaxis in HIV-infected adults in Botswana: a posttrial observational analysis" vol. 29, no. 3, 2015 Export RIS Citation Information.

:

Samandari, Taraz ;

Agizew, Tefera B.

Jan 28 2015 | AIDS. 29(3):351-359

:

ObjectiveThirty-six months of isoniazid preventive therapy (36IPT) was superior to 6 months of IPT (6IPT) in preventing tuberculosis (TB) among HIV-in...
Pregnancy Outcomes in HIV-Infected Women Receiving Long-Term Isoniazid Prophylaxis for Tuberculosis and Antiretroviral Therapy

CITE Title : Pregnancy Outcomes in HIV-Infected Women Receiving Long-Term Isoniazid Prophylaxis for Tuberculosis and Antiretroviral Therapy Personal Author(s) : Taylor, Allan W.;Mosimaneotsile, Barudi;Mathebula, Unami;Mathoma, Anikie;Moathlodi, Ritah;Theebetsile, Irene;Samandari, Taraz; Published Date : Mar 07 2013 Source : Infect Dis Obstet Gynecol. 2013; 2013. URL : https://stacks.cdc.gov/view/cdc/13268 Taylor, Allan W. et al. (2013). Pregnancy Outcomes in HIV-Infected Women Receiving Long-Term Isoniazid Prophylaxis for Tuberculosis and Antiretroviral Therapy. 2013 Taylor, Allan W. et al. "Pregnancy Outcomes in HIV-Infected Women Receiving Long-Term Isoniazid Prophylaxis for Tuberculosis and Antiretroviral Therapy" 2013 (2013) Taylor, Allan W. et al. "Pregnancy Outcomes in HIV-Infected Women Receiving Long-Term Isoniazid Prophylaxis for Tuberculosis and Antiretroviral Therapy" vol. 2013, 2013 Export RIS Citation Information.

:

Taylor, Allan W. ;

Mosimaneotsile, Barudi

Mar 07 2013 | Infect Dis Obstet Gynecol. 2013; 2013.

:

While 6- to 12-month courses of isoniazid for tuberculosis prevention are considered safe in pregnant women, the effects of longer-term isoniazid prop...